BioCentury | Jun 19, 2020
Product Development

InflaRx, Kiniksa anti-inflammatory mAbs yield trend toward lower COVID-19 mortality, plus Sinopharm reports antibody readout from vaccine trial

...interim data showing a trend toward lower mortality in severe COVID-19 pneumonia patients treated with IFX-1...
...CSF2RA - Granulocyte macrophage colony-stimulating factor receptor (CSF2RA) (GMR) (CD116) (GMCSFR) Sandi Wong, Assistant Editor mavrilimumab (cam-3001) CaCP29, IFX-1 InflaRx...
BioCentury | Apr 1, 2020
Product Development

Chinese data propel InflaRx anti-complement mAb into clinic for severe COVID-19 pneumonia

...close Tuesday that it has dosed the first patient in a randomized clinical trial of IFX-1...
...from Beijing Defengrei Biotechnology Co. Ltd. produced by the IFX-1 cell line but distinct from IFX-1...
...Complement 5a MASP2 - Mannan binding lectin serine peptidase 2 (MASP2) Sandi Wong, Assistant Editor CaCP29, IFX-1 InflaRx...
BioCentury | Jun 29, 2019
Finance

Biotech backs down in 2Q19

...bottom of the tier, dropping 92% to $82 million. On June 5, the company announced IFX-1...
...trial to treat hidradenitis suppurativa. The following week it started a Phase II trial of IFX-1...
BioCentury | Jun 5, 2019
Clinical News

InflaRx stumbles after C5a mAb fails in inflammatory skin disease study

...study, InflaRx lost $34.28 (92%) to $3.01 in afternoon trading Wednesday after all doses of IFX-1...
...an unusually high HiSCR rate of 47.1% compared with 38.7-51.5% for the various doses of IFX-1...
...C5aR (CD88) - complement receptor 5a; TNFα - tumor necrosis factor alpha Chris Lieu, Staff Writer CaCP29, IFX-1 InflaRx...
BioCentury | May 11, 2018
Financial News

InflaRx raises $51M follow-on

...follow-on underwritten by J.P. Morgan, Leerink, BMO Capital Markets and SunTrust Robinson Humphrey. InflaRx's IFX-1 (CaCP29...
...to treat rare inflammatory skin disease hidradenitis suppurativa (HS). InflaRx N.V. (NASDAQ:IFRX), Jena, Germany Chris Lieu CaCP29, IFX-1 InflaRx...
BioCentury | Nov 10, 2017
Clinical News

InflaRx reports Phase IIa data of mAb against C5a for rare inflammatory skin disease

...IIa trial in 12 patients with moderate to severe hidradenitis suppurativa showing that IV IFX-1 (CaCP29...
...abscesses and inflammatory nodules) and no increase in abscesses or draining fistulas compared to baseline. IFX-1...
...ANCA)-associated vasculitis is slated to start next half. InflaRx N.V. (NASDAQ:IFRX), Jena, Germany Product: IFX-1 (CaCP29...
BioCentury | Nov 10, 2017
Financial News

InflaRx prices $100M IPO

...million in a series D round (see BioCentury, Oct. 13 ). The company's lead candidate, IFX-1...
...against complement 5a (C5a). In 1Q18, InflaRx plans to start a Phase IIb trial of IFX-1...
...cytoplasmic antibody (ANCA)-associated vasculitis is slated to start next half. InflaRx N.V. (NASDAQ:IFRX), Jena, Germany Allison Johnson IFX-1...
BioCentury | Nov 8, 2017
Financial News

InflaRx prices $100M IPO

...in a series D round (see BioCentury Extra, Oct. 13) . The company's lead candidate, IFX-1...
...against complement 5a (C5a). In 1Q18, InflaRx plans to start a Phase IIb trial of IFX-1...
...vasculitis is slated to start next half. InflaRx was off $0.01 to $14.99 on Wednesday. Allison Johnson IFX-1 InflaRx...
BioCentury | Oct 13, 2017
Financial News

InflaRx raises $55M in series D

...company declined to respond to inquiries. InflaRx plans to conduct a Phase IIb trial of IFX-1...
...autoimmune diseases. Last month, the company said data from a Phase IIa trial showed that IFX-1...
...to biological treatments, including anti- tumor necrosis factor (TNF) alpha therapy. InflaRx has also studied IFX-1...
BioCentury | Oct 13, 2017
Financial News

InflaRx raises $55M in series D round

...company declined to respond to inquiries. InflaRx intends to conduct a Phase IIb study of IFX-1...
...and autoimmune indications. Last month, the company said results of a Phase IIa trial showed IFX-1...
...to biological treatments, including anti- tumor necrosis factor (TNF) alpha therapy. InflaRx has also studied IFX-1...
Items per page:
1 - 10 of 20